326 related articles for article (PubMed ID: 8057484)
1. Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV.
Shimizu N; Tanabe-Tochikura A; Kuroiwa Y; Takada K
J Virol; 1994 Sep; 68(9):6069-73. PubMed ID: 8057484
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata.
Komano J; Sugiura M; Takada K
J Virol; 1998 Nov; 72(11):9150-6. PubMed ID: 9765461
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic role of Epstein-Barr virus in human cancer.
Takada K; Shimizu N; Tanabe-Tochikura A; Kuroiwa Y
Intervirology; 1995; 38(3-4):214-20. PubMed ID: 8682619
[TBL] [Abstract][Full Text] [Related]
4. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
Gregory CD; Rowe M; Rickinson AB
J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata.
Komano J; Maruo S; Kurozumi K; Oda T; Takada K
J Virol; 1999 Dec; 73(12):9827-31. PubMed ID: 10559294
[TBL] [Abstract][Full Text] [Related]
6. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
[TBL] [Abstract][Full Text] [Related]
7. Role of bcl-2 in Epstein-Barr virus-induced malignant conversion of Burkitt's lymphoma cell line Akata.
Komano J; Takada K
J Virol; 2001 Feb; 75(3):1561-4. PubMed ID: 11152530
[TBL] [Abstract][Full Text] [Related]
8. Efficient EBV superinfection of group I Burkitt's lymphoma cells distinguishes requirements for expression of the Cp viral promoter and can activate the EBV productive cycle.
Evans TJ; Jacquemin MG; Farrell PJ
Virology; 1995 Feb; 206(2):866-77. PubMed ID: 7856099
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-encoded poly(A)(-) RNA supports Burkitt's lymphoma growth through interleukin-10 induction.
Kitagawa N; Goto M; Kurozumi K; Maruo S; Fukayama M; Naoe T; Yasukawa M; Hino K; Suzuki T; Todo S; Takada K
EMBO J; 2000 Dec; 19(24):6742-50. PubMed ID: 11118209
[TBL] [Abstract][Full Text] [Related]
10. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
11. An Epstein-Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA.
Takada K; Horinouchi K; Ono Y; Aya T; Osato T; Takahashi M; Hayasaka S
Virus Genes; 1991 Apr; 5(2):147-56. PubMed ID: 1647567
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis.
Ruf IK; Rhyne PW; Yang C; Cleveland JL; Sample JT
J Virol; 2000 Nov; 74(21):10223-8. PubMed ID: 11024153
[TBL] [Abstract][Full Text] [Related]
13. Replacement of the Epstein-Barr virus plasmid with the EBER plasmid in Burkitt's lymphoma cells.
Maruo S; Nanbo A; Takada K
J Virol; 2001 Oct; 75(20):9977-82. PubMed ID: 11559830
[TBL] [Abstract][Full Text] [Related]
14. Low expression of lymphocyte function-associated antigen (LFA)-1 and LFA-3 adhesion molecules is a common trait in Burkitt's lymphoma associated with and not associated with Epstein-Barr virus.
Billaud M; Rousset F; Calender A; Cordier M; Aubry JP; Laisse V; Lenoir GM
Blood; 1990 May; 75(9):1827-33. PubMed ID: 1691936
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus genome studies in Burkitt's and non-Burkitt's lymphomas in Uganda.
Olweny CL; Atine I; Kaddu-Mukasa A; Owor R; Andersson-Anvret M; Klein G; Henle W; de-Thé G
J Natl Cancer Inst; 1977 May; 58(5):1191-6. PubMed ID: 192894
[TBL] [Abstract][Full Text] [Related]
16. Role of Epstein-Barr virus in Burkitt's lymphoma.
Takada K
Curr Top Microbiol Immunol; 2001; 258():141-51. PubMed ID: 11443859
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma.
Nanbo A; Inoue K; Adachi-Takasawa K; Takada K
EMBO J; 2002 Mar; 21(5):954-65. PubMed ID: 11867523
[TBL] [Abstract][Full Text] [Related]
18. Characterization and comparison of two newly established Epstein-Barr virus (EBV)-negative and EBV-positive Burkitt's lymphoma cell lines. EBV-negative cell line with a low level of expression of ICAM-1 molecule and EBV-positive cell line with a high level of expression of ICAM-1 molecule.
Abe M; Tasaki K; Tominaga K; Fukuhara S; Imai S; Osato T; Wakasa H
Cancer; 1992 Feb; 69(3):763-71. PubMed ID: 1309680
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of the polyamine regulator spermidine/spermine N(1)-acetyltransferase by Epstein-Barr virus in a Burkitt's lymphoma cell line.
Shi M; Gan YJ; Davis TO; Scott RS
Virus Res; 2013 Oct; 177(1):11-21. PubMed ID: 23891576
[TBL] [Abstract][Full Text] [Related]
20. Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus.
Rooney C; Howe JG; Speck SH; Miller G
J Virol; 1989 Apr; 63(4):1531-9. PubMed ID: 2538644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]